NewsMateria's Malta EU-GMP Approval Opens-Up European Medical Market To...

Materia’s Malta EU-GMP Approval Opens-Up European Medical Market To Firm

-

MEDICAL cannabis and CBD wellness company Materia has won EU-GMP certification for its Malta facility allowing it to begin processing and exporting cannabis flower across Europe – including the lucrative German market.

The European Union Good Manufacturing Practices (EU GMP) certification has been issued to the London-based supplier and distributor by the Malta Medicines Authority.

It has been hailed by Materia’s chief executive, Deepak Anand, as a “significant milestone.” As most European countries require the EU GMP certification for companies to import and export cannabis goods. 

Mr Anand said: “We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis processor to the industry, especially global partners seeking access to the European market.”

Deepak Anand, Chief Executive Officer at Materia.

The company founded in 2018 and with a production and distribution network covering Germany, the UK, Malta and Denmark, also intends to imminently apply for a licence amendment to process cannabis extracts, leveraging the comprehensive preparatory work already completed.

Nick Pateras, Materia’s managing director, Europe, said: “We are tremendously proud to join the small group of cannabis companies with an EU GMP certified facility.

“Our team in Malta has been relentless in pursuit of this goal and adapted exceptionally to the circumstances of the last year, demonstrating why we consider them amongst the industry’s best.

“Having successfully developed our envisioned European infrastructure, commercialization now becomes our focus.” 

It took over two years for Materia to develop and prepare its Malta facility for inspection to successfully gain the EU GMP certification.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations

After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global...

Transparency For Cannabis Pilot Trials In Switzerland

PRESS RELEASE FOR the first time, cannabis is being sold legally in Switzerland. On 30 January, selected participants of the...

New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

AT the end of 2022 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) held its first ‘technical...

Tetra Pharm Technologies Secures €9 Million In Series A Round To Expand R&D Operations

PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a...

European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues

Oxford Cannabinoid Technologies  THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the...

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.  On Tuesday,...

Must read

A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations

After 60-plus years of negativity and prohibition the tide...

New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

AT the end of 2022 the European Monitoring Centre...

You might also likeRELATED
Recommended to you